5a14: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Human CDK2 with type II inhibitor== | ==Human CDK2 with type II inhibitor== | ||
<StructureSection load='5a14' size='340' side='right' caption='[[5a14]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='5a14' size='340' side='right'caption='[[5a14]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5a14]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5A14 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5A14 FirstGlance]. <br> | <table><tr><td colspan='2'>[[5a14]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5A14 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5A14 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=LQ5:1-[4-(2-AZANYLPYRIMIDIN-4-YL)OXYPHENYL]-3-[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]UREA'>LQ5</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=LQ5:1-[4-(2-AZANYLPYRIMIDIN-4-YL)OXYPHENYL]-3-[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]UREA'>LQ5</scene></td></tr> | ||
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5a14 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5a14 OCA], [http://pdbe.org/5a14 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5a14 RCSB], [http://www.ebi.ac.uk/pdbsum/5a14 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5a14 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5a14 OCA], [http://pdbe.org/5a14 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5a14 RCSB], [http://www.ebi.ac.uk/pdbsum/5a14 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5a14 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
Line 18: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5a14" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5a14" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Cyclin-dependent kinase 3D structures|Cyclin-dependent kinase 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | |||
[[Category: Large Structures]] | |||
[[Category: Alexander, L T]] | [[Category: Alexander, L T]] | ||
[[Category: Bountra, C]] | [[Category: Bountra, C]] |